BioMarin(美国)

BioMarin Pharmaceutical

美国BioMarinPharmaceutical www.bmrn.com美国生物制药公司BioMarinBioMarindevelopsandcommercializesinnovativebiopharmaceuticalsforseriousdiseasesandmedicalconditions,focusingonproductcandidatesthat:Addresscurrentl yunmetmedicalneedsSuggestaclear-cutdevelopmentprofileProvideanopportunitytobefirst-to-marketThecompany'sproductportfolioiscomprisedofthreeapprovedproductsandmultipleinvestigationalproductcandidates.FDA-approvedproductsincludeKuvan®(sapropterindihydrochloride)TabletsforPKU,anoralsmallmoleculetherapeuticdevelopedinpartnershipwithMerckSerono;Naglazyme®(galsulfase)formucopolysaccharidosisVI(MPSVI),aproductwhollydevelopedandcommercializedbyBioMarin;andAldurazyme®(laronidase)formucopolysaccharidosisI(MPSI),aproductwhichBioMarindevelopedthrougha50/50jointventurewithGenzymeCorporation.Investigationalproductcandidatesi